Fig. 4From: The frequencies of CYP2D6 alleles and their impact on clinical outcomes of adjuvant tamoxifen therapy in Syrian breast cancer patientsKaplan–Meier estimates of DFS according to CYP2D6*4 genotype (1847G > A) in the successfully genotyped patients (n = 95)Back to article page